DK0485491T3 - Kunstig biologisk membran - Google Patents

Kunstig biologisk membran

Info

Publication number
DK0485491T3
DK0485491T3 DK90912527.0T DK90912527T DK0485491T3 DK 0485491 T3 DK0485491 T3 DK 0485491T3 DK 90912527 T DK90912527 T DK 90912527T DK 0485491 T3 DK0485491 T3 DK 0485491T3
Authority
DK
Denmark
Prior art keywords
pct
elastin
reactants
sec
biological membrane
Prior art date
Application number
DK90912527.0T
Other languages
Danish (da)
English (en)
Inventor
Michel Rabaud
Francoise Lefebvre
Original Assignee
Inst Nat Sant Et De La Rech M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sant Et De La Rech M filed Critical Inst Nat Sant Et De La Rech M
Application granted granted Critical
Publication of DK0485491T3 publication Critical patent/DK0485491T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0068—General culture methods using substrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Prostheses (AREA)
DK90912527.0T 1989-07-20 1990-07-20 Kunstig biologisk membran DK0485491T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8909798A FR2649982B1 (fr) 1989-07-20 1989-07-20 Membrane biologique artificielle

Publications (1)

Publication Number Publication Date
DK0485491T3 true DK0485491T3 (da) 1995-07-03

Family

ID=9383983

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90912527.0T DK0485491T3 (da) 1989-07-20 1990-07-20 Kunstig biologisk membran

Country Status (9)

Country Link
US (1) US5416074A (de)
EP (1) EP0485491B1 (de)
JP (1) JP2790374B2 (de)
AT (1) ATE119167T1 (de)
DE (1) DE69017453T2 (de)
DK (1) DK0485491T3 (de)
ES (1) ES2069087T3 (de)
FR (1) FR2649982B1 (de)
WO (1) WO1991001393A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251701B (it) * 1991-10-16 1995-05-19 Angra Srl Soluzione di collagene marino con elastina e relativo metodo di estrazione.
DE9116113U1 (de) * 1991-12-30 1993-04-29 Quelle, Gerhard, 6948 Wald-Michelbach, De
CN1091315A (zh) * 1992-10-08 1994-08-31 E·R·斯奎布父子公司 血纤维蛋白封闭剂组合物及其使用方法
CA2262446A1 (en) * 1996-08-07 1998-02-12 Protein Specialties, Ltd. Self-aligning peptides derived from elastin and other fibrous proteins
US6489446B1 (en) 1996-08-07 2002-12-03 Hsc Research And Development Limited Partnership Self-aligning peptides modeled on human elastin and other fibrous proteins
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
EP1196510A4 (de) * 1999-05-28 2007-01-17 Providence Health Sys Oregon Methoden zur produktion von laminiertem elastin, auf elastin basierende materialien und tropoelastinprodukte zur gewebe-wiederherstellung und -ersetzung
US6491061B1 (en) 2000-02-25 2002-12-10 University Of New Mexico Stimuli responsive hybrid materials containing molecular actuators and their applications
US20030022146A1 (en) * 2001-07-26 2003-01-30 Cunanan Crystal M. Oxidized bioprosthetic materials
DE10157182A1 (de) * 2001-11-22 2003-06-05 Matricel Gmbh Verfahren zur Behandlung von Materialien biologischen Ursprungs und Elastin-Produkt
US8377484B1 (en) 2004-05-06 2013-02-19 Maria V. Tsiper Tumor encapsulation for prevention and treatment of metastatic cancer disease
CN1903143A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工血管及其制备方法
CN1903144A (zh) * 2005-07-29 2007-01-31 广东冠昊生物科技有限公司 生物型人工韧带及其制备方法
CN100482178C (zh) * 2005-08-04 2009-04-29 广东冠昊生物科技有限公司 带生物膜的血管瘤夹
JP2007045722A (ja) * 2005-08-08 2007-02-22 Kyushu Institute Of Technology 水溶性エラスチンとそれを含む食品及び医薬
CN1986001B (zh) * 2005-12-20 2011-09-14 广东冠昊生物科技股份有限公司 生物护创膜
CN1985778B (zh) * 2005-12-20 2010-10-13 广东冠昊生物科技股份有限公司 生物型人工角膜
CN1986007B (zh) * 2005-12-20 2011-09-14 广东冠昊生物科技股份有限公司 生物型外科补片
CN1986006A (zh) 2005-12-20 2007-06-27 广州知光生物科技有限公司 生物型神经导管
US20100023129A1 (en) * 2008-07-22 2010-01-28 Guo-Feng Xu Jawbone prosthesis and method of manufacture
CN101332316B (zh) * 2008-07-22 2012-12-26 广东冠昊生物科技股份有限公司 生物型鼻梁植入体
CN101332314B (zh) * 2008-07-22 2012-11-14 广东冠昊生物科技股份有限公司 生物型关节软骨修补件
EP2155233A2 (de) * 2007-05-10 2010-02-24 Elastin Specialties, Inc. Synthetisches peptidmaterial zur gelenkrekonstruktion, -reparatur und -polsterung
WO2020205686A1 (en) * 2019-03-29 2020-10-08 Innovative Orthopedics, LLC Cartilage replacement compositions and methods

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2843963A1 (de) * 1978-10-09 1980-04-24 Merck Patent Gmbh Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4600533A (en) * 1984-12-24 1986-07-15 Collagen Corporation Collagen membranes for medical use
FR2598423B1 (fr) * 1985-03-01 1989-03-17 Inst Nat Sante Rech Med Produit a base d'elastine, procede pour sa preparation et ses applications biologiques, en particulier en tant que biomateriaux et supports artificiels
GB8618374D0 (en) * 1986-07-28 1986-09-03 Hsc Res Dev Corp Biological vascular prostheses
IN171198B (de) * 1987-02-24 1992-08-15 Digital Equipment Corp
GB8800276D0 (en) * 1988-01-07 1988-02-10 Univ Liverpool Medical treatment

Also Published As

Publication number Publication date
JP2790374B2 (ja) 1998-08-27
FR2649982B1 (fr) 1991-09-27
EP0485491B1 (de) 1995-03-01
JPH04506971A (ja) 1992-12-03
ATE119167T1 (de) 1995-03-15
DE69017453D1 (de) 1995-04-06
US5416074A (en) 1995-05-16
FR2649982A1 (fr) 1991-01-25
DE69017453T2 (de) 1995-10-19
ES2069087T3 (es) 1995-05-01
WO1991001393A1 (fr) 1991-02-07
EP0485491A1 (de) 1992-05-20

Similar Documents

Publication Publication Date Title
DK0485491T3 (da) Kunstig biologisk membran
DK1244705T3 (da) Serpentintransmembrane antigener udtryk i human prostatacancere og anvendelser deraf
DK1086223T3 (da) Nye serpentintransmembranantigener udtrykt i humane cancerformer og anvendelser deraf
CY1110927T1 (el) Αμινο-καταληκτικως διακλαδισμενη rantεs ως ανταγωνιστης των χημοκινων
ATE198980T1 (de) Bioabbaubare polymere zur zelltransplantation
DE69033710D1 (de) Sekretion vom mit Gamma-Interferon Signalpeptid gebundenen humänen Protein
ATE308558T1 (de) Hiv-1- und hiv-2-peptide zur hemmung von mit membranfusionen in zusammenhang stehenden phänomenen, einschliesslich der übertragung von hiv
DE10075019I2 (de) Neue Proteine mit TNF-Hemmender Wirkung und ihre Herstellung.
ES2300276T3 (es) P40 de interleuquina-12 de mamifero e interleuquina b30. sus combinaciones. anticuerpos. usos en composiciones farmaceuticas.
DE69942035D1 (de) Menschliches parathyroidhormon, modifikationen, herstellung und verwendung
DK83093D0 (da) Fremgangsmaade
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
DK491487D0 (da) Dna-sekvens til ekspressionering af biologisk aktivt faktor xiii og anvendelse af samme
BR9810701A (pt) Proteìna "swollenina" de trichoderma reesei e seqâências de codificação de dna
FR2700169B1 (fr) Nouveaux variants trans-dominants TAT du virus de l'immunodéficience humaine.
ES2060580T3 (es) Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.
DE69103875D1 (de) Reinigung von Sole für Chlor-Alkali-Membranzellen.
ATE273322T1 (de) Tfpi-verwandte peptide die das wachstums von glatten muskelzellen inhibieren
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
RU93005126A (ru) Гелонин, днк
DE69011626D1 (de) Reinigung von Chloralkalimembranzellsole.
FR2703054B1 (fr) Promoteur vegetal inductible au stress et cellules vegetales contenant une unite d'expression d'une proteine d'interet comprenant ledit promoteur.
DE3881467T2 (de) Vasokonstriktor-Peptid.
DE69900852T2 (de) Verwendung von isoosmotische salzlösungen zur herstellung von cerumenolytischer pharmazeutischer präparate
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung